ACS (excluding AMI): 2 trials - ASPECT-2 (coumadin vs aspirin) - ASPECT-2 (coumadin+asp vs asp)
All ACS (including AMI): 2 trials - ASPECT-2 (coumadin vs aspirin) - ASPECT-2 (coumadin+asp vs asp)
All type of patients: 2 trials - ASPECT-2 (coumadin vs aspirin) - ASPECT-2 (coumadin+asp vs asp)
All type of patients: 3 trials - ASPECT-2 (coumadin alone) - ASPECT-2 (coumadin+ASA vs ASA) - ASPECT
1 trials - PATAF (coumadin low dose vs coumadin standard dose)
3 trials - ASPECT-2 (coumadin alone) - ASPECT-2 (coumadin+ASA vs ASA) - ASPECT